In this study, to find new therapeutic targets and develop potential 1,25VD3-based treatments for AML, we explored the comprehensive details of how 1,25VD3 works on the metabolism of FLT3-mutated blasts. This evidence concerns the gene FLT3 and acute myeloid leukemia.